Restalyst has been in the research & development (R&D) of novel cancer biomarkers for in vitro diagnostic (IVD) manufacturing industry for over 15 years and is specialised in immunoassay, particularly for early detection and diagnosis of oncology and infectious diseases.
Restalyst is ISO 13485 certified and is strategically located in Singapore, the heart of Southeast Asia, where it provides easy access to quality resources as well as excellent global connectivity to serve the fast-growing markets in the region and beyond.
We portray a strong market presence in Southeast Asia, and we have partnerships with reputable medical laboratories, research institutions, and distributors in the region.
Restalyst is capable to supply raw materials and manufacture your customised product(s) beginning from product concept to realisation. Our capability and expertise have positioned us in the market within the diagnostics and biotech industry. Restalyst offers IVD manufacturers, research institutions, and contract research organisations (CROs) a comprehensive range of products and services from “raw material to finished product”.
A summary process of CDMO in Restalyst: